AstraZeneca Pharma India Ltd Q1 Results
- BSE: 506820
- NSE: ASTRAZEN
- ISIN: INE203A01020
- Sector: Biotechnology & Drugs
BSE
8,550.00
-73.00 (-0.85%)
-73.00 (-0.85%)Volume207.00
Updated: Fri 6 Feb, 2026 | 15:29:02
NSE
8,557.50-64.00 (-0.74%)
-64.00 (-0.74%)Volume4.57 K
Updated: Fri 6 Feb, 2026 | 15:29:33
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
Quarter ended Jun 25
Note: Comparison is on QoQ basis
Quarterly - AstraZeneca Pharma India Ltd Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 25 | Mar 25 | QoQ Comp | Jun 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 462.13 | 417.48 | 10.70% | 410.92 | 12.46% |
| Depreciation/ Amortization | 16.57 | 17.69 | -6.33% | 3.91 | 323.79% |
| Operating Income | 64.18 | 63.00 | 1.87% | -23.40 | 0.00% |
| Net Income | 55.83 | 58.25 | -4.15% | -11.79 | 0.00% |
| Other Operating Expenses Total | 61.11 | 47.35 | 29.06% | 40.70 | 50.15% |
| Net Income Before Taxes | 74.70 | 78.47 | -4.80% | -15.16 | 0.00% |
| Total Revenue | 526.31 | 480.48 | 9.54% | 387.52 | 35.81% |
| Selling/ General/ Admin Expenses Total | 88.68 | 87.15 | 1.76% | 78.31 | 13.24% |
| Diluted Normalized EPS | 22.44 | 25.01 | -10.27% | 10.26 | 118.73% |